Tell a FriendPrint

Board of Directors

Mr. Terry Bond

Terry Bond, Executive Chairman

Prior to its merger with ViaLogy, Terry was managing director and deputy chairman of Original Investments (formerly BioProjects International), an investment company quoted on the Alternative Investment Market of the London Stock Exchange. In addition Terry is a director of Sector Investment Managers Ltd, the company that advises Junior Oils Unit Trust, an authorized unit trust in the UK.

After an early career in journalism, including spells with a number of UK national newspapers and the BBC, Terry headed an international public relations consultancy based in London. In the Eighties he was appointed sales and marketing director for Wimpey Leisure, the overseas property division of George Wimpey PLC, one of the UK’s largest housebuiders.

In 1993 Terry joined the board of ProShare (UK) Ltd, an organisation set up by the government and the stock exchange to encourage responsible share ownership, and was responsible for development of the investment club movement in the UK, and the establishing of 12,000 investment clubs. He was a member of the government’s Waterstone Committee which investigated and reported on the relationship between private investors and smaller quoted companies.

Terry is the author of the investment book, ‘The Company of Successful Investors’.


Dr. Robert W. Dean

Robert W. Dean, President and CEO

Bob joined ViaLogy in October, 2007. Previously, he held senior executive positions with SAIC, Boeing, Lockheed Martin and Ball Aerospace Corp. Bob also served in senior executive positions in the U.S. government at the State Department and at the White House as Special Assistant to the President during Ronald Reagan's presidency. He is a graduate of Brandeis University, Harvard University, and received his Ph.D. from the University of Denver.

 


Dr. Sandeep Gulati

Dr. Sandeep Gulati, VP/Product Development & CTO

At ViaLogy, he developed a novel sensor-agnostic, signal characterization technology, Quantum Resonance Interferometry ("QRI") to detect and quantify weak signals and events in high clutter and background noise. His current work focuses on development and commercialization of QuantumRD for reservoir characterization; and development of new workflow sequences for de-risking stratigraphic resource plays, optimal frac design and real-time monitoring and enhanced oil recovery. His activities have ranged from applying QRI for drug target discovery, mass spectrometry and subsurface synthetic aperture radar application for buried pipeline, utilities and object detection. At ViaLogy he also led the development of Sensor Policy Manager (SPM) for large scale network-centric integration of sensors over converged IP networks for applications in public safety, security and surveillance.

Prior to joining ViaLogy, Dr. Gulati headed the Ultracomputing Technologies Group at NASA's Jet Propulsion Lab in Pasadena, CA. During his 12 year tenure at JPL, he led computational advances in spacecraft autonomy, autonomous diagnostics and prognostics of complex systems, sensor fusion, neural networks, signal processing, command decision modeling and intelligence analysis. At JPL he was a Principal Scientist on a number of large programs of national relevance for NASA, DOD and other government agencies. He has consulted extensively with the financial services, entertainment, healthcare and aerospace firms.

Dr. Gulati has 14 issued US patents and over 100 publications in archival journals and conference proceedings.


Mr. Peter Reynolds

Peter Reynolds, Non-Executive Director

Peter Reynolds has spent over thirty years as a director of a range of both public and private companies.

Return to top ^